biote Corp.
biote Corp. (BTMD): ~2 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
2-factor signal · derived from public data
1.6 months
D/E -2.44
N/A
N/A
N/A
N/A
A transparent, data-derived signal for biote Corp.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$80.9M
Cash
$5.3M
Quarterly Burn
$27.8M
Runway
1.6 mo
Revenue
$44.9M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
83
Total value held
$18.3M
| Holder | Shares | Value |
|---|---|---|
| 325 capital llc | 4,548,127 | $6.1M |
| vanguard capital management llc | 2,227,710 | $3.0M |
| blackrock, inc. | 1,739,244 | $2.3M |
| state street corp | 646,954 | $873K |
| geode capital management, llc | 615,662 | $831K |
| dimensional fund advisors lp | 543,494 | $734K |
| globeflex capital l p | 272,400 | $368K |
| northern trust corp | 269,113 | $363K |
| renaissance technologies llc | 265,916 | $359K |
| rice hall james & associates, llc | 250,019 | $338K |
Showing top 10 of 83 institutional holders of biote Corp.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
What is biote Corp.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, biote Corp. has approximately 1.6 months of cash runway.
What is biote Corp.'s market capitalization?
biote Corp.'s market capitalization is approximately $80.9M.
Who is the CEO of biote Corp.?
Mr. Bret Christensen is the chief executive officer of biote Corp. (BTMD).
Get the full picture on biote Corp.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.